Introduction
The use of alcohol and drugs may have negative effects on psychomotor functions such as coordination, alertness and vision. In addition, it can lead to aggressiveness and reduced reaction time, poor judgment and increased risk taking (1, 2) . These effects are detrimental and unfortunate for the users. Excessive use of alcohol or drugs may cause problems such as accidents, violence, suicidal behavior, absence from work, reduced performance and unemployment (2, 3) . The extent of drug use in the younger adult population in Norway is not fully known. For the last decades, the use of alcohol and drugs among adolescents and young adults in Norway has been studied using questionnaires (4) . During the last years, the response rate has, however, dropped from over 90% to below 30%; this research has now been stopped because of the low participation (5) . New methods to study and monitor the use of alcohol and drugs among young adults in Norway are therefore needed.
An alternative way to assess drug and alcohol use is the analysis of biological samples, preferably those that are easily collected. The Norwegian Institute of Public Health (NIPH) has previously carried out different epidemiological studies of alcohol and drug use employing questionnaires combined with samples of saliva, urine or blood (6) (7) (8) (9) (10) . Hair sample as an analytical matrix for epidemiological studies has, however, not previously been evaluated in Norway. One study has investigated patterns in drug use in the UK in a large population between 2001 and 2005, and the authors concluded that the chances of identifying people using drugs by testing hair samples were twice as high as by using urine samples (11) .
Hair samples can be an important matrix for the detection of drug use. Drugs are deposited from the bloodstream to the keratinized hair fiber in the hair follicle, but can also be incorporated from sweat, sebum and the external environment (12 -16) . Head hair grows 1 cm per month, and drug findings in 1 cm represent the drug intake during 1 month (17 -19) . This gives hair a long surveillance window (months, and up to years for some compounds) for persons with long hair (13) . There are, however, variations in growth rate among sex, age and race (20) . Drugs in hair are relatively stable, sample collection is easy, the procedure is noninvasive, and storage is much less demanding than for other biological media such as urine or blood (21) . Hair is not infectious unless it is contaminated with blood, urine or other contaminants on random occasions. These facts make the matrix promising as a tool for epidemiological research on drug abuse. The common steps in hair analyzing methods often include external decontamination of hair, extraction of drugs and then analysis (20) .
There are some disadvantages with hair as a specimen for drug testing. Hair is not suited to detect recent drug use because it takes 7 -10 days for drugs and metabolites to appear in it, it demands relatively expensive and time-consuming analytical methods, sample collection is dependent on hair being present, and its length and color can bias the results (20) . False-positive results due to environmental or external contamination might be a problem, but appropriate wash procedures and cutoff values for the measured compounds can distinguish external contamination from active drug use (20) .
The first aim of this feasibility study was to analyze hair samples collected from hair salons to estimate the use of illegal and psychoactive medicinal drugs, nicotine products and alcohol and to compare the results with data collected by other relevant studies. The second aim of the study was to assess whether relatively simple hair testing can be used to obtain reliable population data for general studies on drug use.
Materials and methods
Study design, setting and participants During the period from December 2010 to June 2011, five hair salons from the southern part of Norway were asked to collect altogether 200 hair samples. The salons collected on average 40 samples each.
Samples from both men and women aged between approximately 18 -40 years were obtained from the first 40 customers after the collection started. Clients' ages were assessed by the hairdresser without asking them, and they were not informed about the study. As a result, the "participation rate" was 100%. It was impossible to identify the sample donor later. Only one sample from each client was collected and steps were taken to ensure that hair samples from several persons were not mixed in the collection. No information about the participant, his/her hair length or any previous hair treatment was recorded. The participating hairdressers received an award of NOK 50 (about 8 US$) per sample collected. This feasibility study was designed so that the collection, preparation and analysis of the samples made as little demand as possible on resources and full anonymity was provided for the participants.
The samples were collected during the normal course of the haircut, with no additional material taken. The sampling was done before styling products were added, and it was done with clean fingers; the hairdresser was instructed to clean hers/his fingers before sample collection. They were also trained to collect at least 200 mg of hair in each sample to ensure a sufficient amount of matrix.
Sample preparation
The hair sample was covered by aluminum foil immediately after collection, and the foil was folded and put in an envelope and delivered to the NIPH for analysis. Each hair sample was homogenized by manual cutting with a pair of scissors and weighed out in appropriate amounts before analysis.
Analysis
The samples were analyzed for psychoactive illicit drugs, benzodiazepines, cotinine, opioids, zolpidem and zopiclone (all compounds mentioned in Table I except from D9-tetrahydrocannabinol (THC) and ethyl glucuronide, EtG) by the same method. Twenty milligrams of hair sample was weighed out, and analysis was done using LC-MS-MS (Surveyor MS Pump and auto-sampler and TSQ Quantum Discovery MAX, Thermo Fisher Scientific, Inc., Boston, MA, USA) with a Zorbax SB-Phenyl (3.5 mm 2.1 Â 100 mm) column (Agilent Technologies, Santa Clara, CA, USA) after sample extraction in 5% acetonitrile in 25 mM acetic acid at 378C for 18 h. The mobile phase consisted of acetonitrile and 25 mM acetic acid and gradient elution were used (17) . Four calibration standards were used for each compound in this method. The calibration ranges are mentioned in Table I .
EtG was analyzed by a second method. An amount of 60 to 70 mg of hair sample was weighed out and put in tubes with a screw top. They were washed with 5 mL of dichloromethane for 10 min in an ultrasound bath. The samples were then dried and 50 mg dry hair was weighed out before further sample preparation. Two milliliter H 2 O and 50 mL of 80 ng/mL EtG d5 in H 2 O (internal standard) were added before ultrasound bath for 2 h and overnight incubation at ambient temperature. The samples were then extracted by solid-phase extraction (Hyper-SEP SAX/ 3 mL/200 mg, Thermo Fisher Scientific, Inc., Boston, MA, USA). They were analyzed using UPLC-MS-MS (Acquity UPLC and Quattro Premier XE, Waters Corporation, Milford, MA, USA) with an HSS T3 (1.8 mm 2.1 Â 100 mm) column and a gradient elution of the mobile phase with methanol and 0.1% acetic acid. The injection volume was 3.5 mL, and a partial loop with needle overfill was used. The column temperature was 658C. Table II shows the elution program that was used.
The third method was used to analyze THC. Ten milligrams of hair sample was weighed out and put in 15 mL tubes, and 25 mL THC d3 1000 ng/mL (internal standard) and 1 mL 2 M NaOH were added. The tubes were then sealed and stirred briefly. The samples were dissolved at 808C for 15 min without stirring before 1 mL H 2 O was added. Five milliliters of hexane were added before the samples were automatically stirred for 10 min and then centrifuged at 4500 rpm for 15 min (Megafuge 2.0 R). The organic layer was then evaporated to dryness, and a derivatization reagent (BSTFA/ACN 1 þ 2) was added and then stored at 608C for 15 min, cooled and evaporated into dryness, resolved in 30 mL of butyl acetate and analyzed using GC-MS (HP 6890 and HP 5973 MSD, Agilent Technologies, Santa Clara, CA, USA) with a Factor Four VF-1MS (15 + 1 m, 0.25 mm id, DF 0.4 mm) column and a 5 m EZ-quard precolumn. Six calibrator standards were used with the range mentioned in Table I .
Every assay was run with a blank, a blind sample, calibration standards and calibrations control standards (QC samples). Linear calibration curves were used with a limit of linearity of 0.99. Determination was done with calibrators and QC samples set at linearity points for reporting. All compounds and cutoff concentrations are presented in Table I . Reference standards were obtained from Cerilliant (Round Rock, TX, USA), Sigma (St Louis, MO, USA) and Lipomed AG (Arlesheim, Switzerland). The Norwegian Institute of Public Health participates in an external quality control program for hair sample analysis in which the three analytical methods applied in this study are tested on a regular basis.
Statistical methods
Statistical analyses and graphical presentation of the results were carried out using PASWw Statistics (SPSS version 17) and Microsoft Excel 2003. Associations between positive samples and hair salon were analyzed using bi-variate cross tables. Chi-square statistics were used to assess the statistical significance. The level of statistical significance was set as P , 0.05 or P , 0.01.
Ethics
The study was approved by the Regional Committee for Medicinal and Health Research Ethics. The sample collection was performed anonymously, without any registration of personal data. The hairdressers were instructed not to mark the envelopes in any way. Approval from the Regional Committee for Medicinal and Health Research Ethics was thereby given to collect samples without consent. The hairdressers removed 200 mg or more of hair in the course of the haircut with no additional hair being removed from the individual for the purpose of the study. The hair samples were collected after the client had left the salon. The hairdressers were instructed to exclude minors and discretely ask about the age if they were unsure.
Results
Forty-seven of the collected samples (23.5%) contained at least one compound. The following compounds were not detected in the hair samples: 6-acetylmorphine (6-AM), amphetamine, buprenorphine, carisoprodol, meprobamate, morphine and zolpidem. There were no significant differences in the findings on the prevalence of drugs in the samples from different salons (P ¼ 0.063). Some of the participants tested positive for more than one compound.
Tobacco
This study did not measure nicotine, but the metabolite cotinine. Nicotine is often detected in hair after contamination from passive smoking, and the compound is therefore not the best biomarker for tobacco use. As a result, cotinine has become the biomarker of choice for tobacco-smoking exposure (22) . The prevalence of cotinine in the samples was 11.5% (n ¼ 23).
Alcohol
Ethanol cannot be found in hair samples. However, the metabolite EtG is a specific biomarker of ethanol intake that can be analyzed in hair. EtG was found in 2.5% (n ¼ 5) of the collected samples. The concentrations of EtG varied from 23 to 72 pg/mg.
Illicit drugs
The prevalence of illicit drugs in the samples was 5% (n ¼ 10). The most frequently found drug was THC, which was found in six cases (3%). The second most frequently found illicit compound was cocaine (n ¼ 5, 2.5%). Benzoylecgonine, a metabolite from cocaine, was found in two of the cocaine-positive samples (1%). One of these cocaine and benzoylecgonine-positive samples was, in addition, positive for methamphetamine. One participant tested positive for 3,4-methylenedioxymethamphetamine (ecstasy).
Benzodiazepines and z-hypnotics
The prevalence of benzodiazepines and z-hypnotics was 9.5% (n ¼ 19). Table III shows the distribution of the results. Benzodiazepines were found most frequently. The compound most frequently detected was oxazepam (n ¼ 6, 3%), which is sold as a tranquilizer. This compound is, in addition, a metabolite of diazepam (anxiolytic) and, in one of these samples, a concurrent finding of diazepam was registered. Diazepam was also found in four other samples. The nitrobenzodiazepines clonazepam, flunitrazepam and nitrazepam were found as their respective 7-aminometabolites (7-aminoclonazepam, 7-aminoflunitrazepam and 7-aminonitrazepam), and the most frequently found nitrobenzodiazepine was 7-aminoclonazepam. Clonazepam is, in Norway, used as an antiepileptic, but has an abuse potential and is commonly found in, for example, driving under the influence of drug cases (23 -25) . Table III shows that benzodiazepines contributed to most of the legal/prescribed drugs. In addition to benzodiazepines, one case was positive for zopiclone (z-hypnotic), one for codeine (analgesic) and one for methadone (an opioid commonly used for opiate maintenance treatment). Opioids were detected in 1.0% of all samples and 4.3% of the positive samples. Benzodiazepines and z-hypnotics were in total found more frequently than illegal drugs.
Discussion
In this study, we collected hair samples from hair salons to investigate whether hair samples of that type can be used to obtain reliable population data for general studies on drug use, when compared with other studies.
Tobacco
Four surveys having questionnaires with a total number of 4500 respondents aged between 16 and 74 years are carried out once a year by Statistics Norway, and the results from 2011 showed that 17% of Norwegians smoked daily, 11% smoked occasionally and 8% of the population used snuff (26) . These numbers suggest that older people are more often smokers than younger people, and/or that the results of our study gave an underestimation of the actual use of nicotine products, and that hair samples from hair salons therefore are not a good biological tool in epidemiological investigations of the use of tobacco or other nicotine products in a population. Cotinine levels in hair may, in addition, be lower in fair hair and higher in dark-colored hair (22, 27) . Chemical hair treatment is also known to reduce the amount of cotinine in hair (28) , and the prevalence may be underestimated if the participants have treated their hair with bleaching, straightening and/or permanent. Whether the participants had undergone cosmetic treatment or not was, however, not registered in this study to ensure full anonymity. Studies have shown that smokers who reported that they had such hair treatments had 66% lower hair-nicotine concentrations (28) . Low results may, in addition, be under the cutoff value of the analytical method and consequently interpreted as negative. If hair testing is submitted in other studies, one must take into account that cotinine can also be incorporated into the hair of passive smokers, and a positive finding is therefore not necessarily a marker of tobacco use. However, the concentrations in hair samples from passive smokers are expected to be ,130 pg/mg (16), which is lower than the cutoff value used in our study, so the influence from passive smoking is probably ruled out in this study. One must, however, keep in mind that there could be individual differences in uptake, distribution and metabolism, and that the concentration of the biomarker in the body may be influenced by those factors (22) . Cotinine is present in concentrations as low as one-tenth of the concentration of nicotine in hair (27) and the detection of cotinine in hair samples from smokers with a low consumption might therefore be difficult. Cotinine concentrations could also be lowered by drugs that are competitive substrates or potent inhibitors of CYP 2A6, and drugs that induce this enzyme may increase or decrease cotinine levels since cotinine is generated and metabolized by CYP 2A6 (29) . Very low concentrations of cotinine in the body challenge a secure detection and interpretation of the compound in hair samples. Variations in concentrations make it difficult to interpret the result because of the above-mentioned factors; a low result may have several causes. Alcohol A small amount (0.02-0.06%) of ingested ethanol is eliminated as EtG (30) . Studies have shown that concentrations of EtG in hair from persons with heavy alcohol abuse ranged from 30 to 13 300 pg/mg (16) . The detection of EtG .30 pg/mg is a strong indicator of heavy alcohol use. Daily intake of 16 g of ethanol (corresponding to 1 glass of wine) was investigated by Kronstad et al., which showed that the EtG concentration in hair was ,7 pg/mg (31) . The concentrations of EtG in this study varied from 23 to 72 pg/mg, which implies that the five positive tests were collected from individuals with higher alcohol consumption. There are unfortunately no relevant data to compare with, as no studies on this particular group of people have yet been published in Norway.
Illicit drugs
The time-frame window for the detection of compounds is longer in hair samples compared with saliva (32) , and one may therefore expect a higher prevalence in hair samples than in saliva samples in random epidemiological studies. This was investigated for illicit drugs by Fendrich et al. in 2001 Fendrich et al. in -2002 and the results showed that fewer people were identified as positive by oral fluid tests than by hair tests (33) . A Norwegian study of the use of alcohol, psychoactive medicinal drugs and illicit drugs in a selection of Norwegian road traffic showed that illicit drugs were found in 1.5% of the collected saliva samples (34) . Illicit drugs were found most frequently in the lower age groups. The prevalence among the people ,40 years of age was 2.7%. Cocaine and/or benzoylecgonine were found in 2.5% of the hair samples and in 0.6% of the saliva samples from young adult drivers. The respective prevalence of THC was 3.0% in hair samples and 2.0% in the saliva samples (Gjerde et al., personal communication). The hair samples showed a prevalence of positive results for illicit drugs of 5%, which is higher than the prevalence among the drivers. The detection of drugs in saliva samples indicates, in general, the drug use during the last 24 -48 h (35 -38) .
THC concentrations in hair samples are low, which make detection and quantification challenging due to limitations in the detection capabilities of the analytical methods (39, 40) . Insufficient sensitivity may lead to an underestimation of the measured prevalence. A report from the Norwegian Institute for Alcohol and Drug Research (SIRUS) stated that 2% of the participants ,35 years had used cannabis during the last 30 days in 2009 (4). In the same age group, the prevalence in the last year was 7%. The numbers from SIRUS were based on self-reports, and one could expect to find a higher prevalence in actual samples compared with self-reported numbers, especially since our study provided a 100% response rate. Huestis et al. have shown that even daily cannabis smoking may not be detected in hair samples, partly because THC is an UV-unstable compound (39) . In 2010, SIRUS conducted a survey in which 4956 persons of the age 18 -30 participated, and a questionnaire was used. About one-third of the respondents reported having tried cannabis at least once (4). The corresponding numbers were 6% for both amphetamine and cocaine. Among the respondents who reported having ever used one of these compounds, about one-third reported the use during the last 6 months. The prevalence for the entire sample population was 9% for cannabis, and ,2% for amphetamine or cocaine. For THC and other illicit drugs, it will be difficult to find the true prevalence in a population as long as participation in studies is voluntary and as long as underreporting in questionnaires is possible. The perfect measurement method has not yet been developed.
Baeck et al. investigated whether repeated hair washing and a single hair dyeing reduced the concentration of methamphetamine and amphetamine in human hair and found that the Suitability of Hair Samples in Epidemiological Studies 365 concentrations in methamphetamine addicts decreased by about one-third in comparison to untreated hair (41) . They suggested that a 10 times or more continuously repeated washing and a single dyeing can similarly affect hair analysis with a consequently decreasing rate of the concentrations of methamphetamine and amphetamine. The prevalence will thus be affected negatively if the hair samples have undergone such treatment. Information about this was, however, not collected from the hairdressers. The measured prevalence of amphetamine and methamphetamine, as is the case for cotinine and THC as well, is therefore probably not representative for the young adult population in Norway. Information about washing and dyeing is necessary for at least these four compounds.
A semi-quantitative relationship between dose and hair concentration has been found for cocaine (42) , and the prevalence of this compound may be interpreted as true without falsepositive or -negative interferences if the samples are being washed prior to analysis as a decontamination step. The hair samples were, however, not washed at the laboratory prior to the analysis, and positive results for cocaine and benzoylecgonine, or THC, may be due to the contamination of the hair and overestimate the results. This was probably not the case in this study. It is possible to distinguish between contaminated and digested cocaine by analyzing the unambiguously endogenous metabolites norcocaine and coca ethylene (40) . This was, however, not done in our study. Benzodiazepines and z-hypnotics were in total detected in 9.5% of all tests. The study conducted by Gjerde et al. of the use of alcohol, psychoactive medicinal drugs and illicit drugs in a selection of Norwegian road traffic showed that medicinal drugs were found in 3.2% of the collected saliva samples (34) . The response rate was 94% in this study, and the actual prevalence might have been a bit higher than 3.2% if some of the 6% who did not participate had ingested drugs prior to driving. The detection window in hair is longer than in saliva, and a higher prevalence is expected from hair samples.
Benzodiazepines and z-hypnotics
Codeine is a commonly used opiate analgesic, but can also be found originating as a metabolite of acetyl codeine, which is a common by-product in illicit heroin, and may be detected in hair in cases of heroin abuse in addition to cases of medicinal use of codeine (40) . A semi-quantitative relationship between dose and hair concentration has been studied for codeine (42) and the interpretation of the use of medicinal codeine is therefore straightforward if heroin abuse can be excluded. Codeine was found in one hair sample, without concomitant morphine or 6-AM. It is therefore assumed that codeine was ingested as a medicinal drug and not as heroin.
Strengths and limitations
The strengths of this study were that the participation and testing were done unannounced and with a method that ensured a participation rate of 100%. The analytical methods ensured a wide and secure screening of the compounds. Moreover, the hairdresser and the location of the salon were known. Limitations of the study were that there was no information about the participants other than age group and that they could afford to see a hairdresser. The small sample size is also a limitation, especially for comparing the results with other epidemiological studies. The study was, however, meant to be a feasibility/pilot study, and 200 samples were sufficient to evaluate whether the study design was appropriate for our aims.
As mentioned earlier, cosmetic hair treatment can reduce drug concentrations and lead to underestimation of prevalence. Drug concentrations may also be related to hair color and introduce ethnical bias (28, 40, 43) . The literature is, however, inconsistent, and there are not necessarily any significant differences between hair color as well as ethnicity and incorporation of drugs into hair (44) . Some compounds bind easier to hair than others. THC is not very well incorporated to hair (39, 40) , while a semi-quantitative relationship has been studied for codeine and cocaine (42) . External contamination might be a problem, but it could be minimized by effective wash procedures, appropriate cutoff values and analysis of endogenous metabolites.
There was no information about the participants' total hair length, the length of each collected sample or how far away from the scalp it was collected. There might have been collected samples that represented drug intake one to several months, even up to years ago depending on the hair length, and as a result the timeframe was not consistent. The point of intake is therefore unknown, and the results may sum up intake from several years ago to 2011 (depending on the length of the hair the sample was taken from), and the prevalence of each compound may have varied from year to year without this study being able to detect these variations. Another problem that may have arisen is a dilution of samples that represent a low drug intake over a short timeframe. If these samples, in addition, were rich in the matrix, hair, the compounds in the samples would have been diluted under the homogenization step of the sample preparation prior to analysis. The fact that it is a lack of information concerning chemical cosmetic treatment or extensive washing makes it challenging to be certain of the results and of the true prevalence of drug use in young adults in the study.
The limitations mentioned above make it difficult to estimate the use of drugs of abuse in the young adult population in Norway. The aim was to study whether hair testing can be used to obtain reliable population data for general studies on drug use. The sampling method used in this study cannot be recommended, but a similar study may collect more reliable population data if hair samples are collected with information about hair length, sample length, length from the scalp, cosmetic treatment and washing frequency, and whether the samples are always washed and decontaminated prior to analysis. The ideal sampling method is to collect samples that are cut near the scalp.
Conclusion
These preliminary findings suggest that the analysis of hair samples may underestimate the use of cannabis, alcohol, amphetamine and methamphetamine, but it may be done to estimate the use of cocaine and benzodiazepines.
The sampling method used in this study was not optimal for the collection of reliable population data. A similar study may, however, collect reliable population data if the hair samples are obtained with information about hair length, sample length, length from the scalp, cosmetic treatment or washing, and whether the samples are always washed and decontaminated prior to analysis. The ideal sampling method is to collect samples that are cut near the scalp. This would provide control of the time frame of use or abuse of drugs, nicotine, alcohol and narcotics.
This study is different from other previously published drugtesting studies in the way that it collected samples from 100% of the participants. It was done as a feasibility study to investigate whether a larger, similar study could be done later to replace, for example, questionnaires. This study contributes with modern and more efficient, and less time-and solvent-consuming techniques within drug analysis, since other studies on hair tests for epidemiological purposes mostly use GC-MS, and this study mostly used LC-MS-MS, UPLC -MS-MS, and only GC-MS for THC detection. The results of this study can be used to design a proper protocol for the collection of hair from hair salons to investigate drug use in a population.
